PT - JOURNAL ARTICLE AU - Yu, Gechang AU - Wu, Xinran AU - Liu, Zhaowen AU - Becker, Benjamin AU - Zhang, Kai AU - Kuang, Nanyu AU - Kang, Jujiao AU - Dong, Guiying AU - Zhao, Xing-Ming AU - Schumann, Gunter AU - Feng, Jianfeng AU - Sahakian, Barbara J. AU - Robbins, Trevor W. AU - Palaniyappan, Lena AU - Zhang, Jie TI - Common and Disorders-Specific Cortical Thickness Alterations in Internalizing, Externalizing and Thought Disorders over a 2-year Period in the Preadolescents of the ABCD Study AID - 10.1101/2021.09.02.21263005 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.02.21263005 4099 - http://medrxiv.org/content/early/2021/11/01/2021.09.02.21263005.short 4100 - http://medrxiv.org/content/early/2021/11/01/2021.09.02.21263005.full AB - Overlap of brain changes across mental disorders has reinforced transdiagnostic models. However, the developmental basis for this overlap is unclear as are neural differences among internalizing, externalizing and thought disorders. These issues are critical to inform the theoretical framework for hierarchical transdiagnostic psychiatric taxonomy. We examined cortical thickness (CT) difference between healthy controls (n=4041) and patients with externalizing (n=1182), internalizing (n=1959) and thought (n=347) disorders in preadolescents (9-10 years) from the Adolescent Brain and Cognitive Development Study using linear mixed models. Genome-wide association analysis and cell type specificity analysis were performed on regional CT across 4,716 unrelated European youth. We found that youth with externalizing or internalizing disorders, but not thought disorders, exhibited significantly thicker cortex than controls. Externalizing and internalizing disorders shared thicker CT in left pars opercularis and caudal middle frontal gyrus related to lower cognitive performance. Somatosensory and primary auditory cortex were uniquely affected in externalizing disorders; primary motor cortex and higher-order visual association areas were uniquely affected in internalizing disorders. Only group of externalizing disorders demonstrated significant CT increase than controls at 2-year follow-up and decelerated cortical thinning from 10 to 12 years old. At genetic level, genes associated with CT in common and disorders-specific regions were also implicated in related diagnostic families. Microglia were the cell-type associated with CT for both externalizing/internalizing while dopaminergic/glutamatergic/GABAergic cells related only to externalizing-specific regions. These results showed that distinct anatomical trajectories relevant to internalizing/externalizing phenotypes may result from unique genetic and cell-type changes, but these occur in the background of significantly shared morphological variance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJZ was supported by Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01) and ZJLab and NSFC 61973086. JF was supported by the 111 Project (No. B18015), the key project of Shanghai Science and Technology (No. 16JC1420402), National Key R&D Program of China (No. 2018YFC1312900), National Natural Science Foundation of China (NSFC 91630314). LP acknowledges salary support from the Tanna Schulich Chair of Neuroscience and Mental Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our research does not need the IRB/oversight body.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGWAS summary statistics of regional CT of 20 ROIs could be downloaded on (https://drive.google.com/drive/folders/1a64gvTM5AQAYLdUw7GQxT-GQN1msXw3H?usp=sharing). https://drive.google.com/drive/folders/1a64gvTM5AQAYLdUw7GQxT-GQN1msXw3H?usp=sharing